Skip to content

PEG ratio at other companies

Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
0.2×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
0.2×
TG Therapeutics logo
TG TherapeuticsTGTX
Biogen logo
BiogenBIIB
0.4×

Other financials

Income statement

See full
Revenue$149.4M+5.6%
Gross profit$134.9M+9.2%
Operating income$73.2M+15.6%
Net income$63.7M+12.3%
EPS (diluted)$0.50+11.1%

Balance sheet

See full
Cash & equivalents$755.9M+30.2%
Total debt$2.7M-13.3%
Total equity$1.0B+27.5%
Total assets$1.1B+26.3%

Cash flow

See full
Operating cash flow$59.6M-0.8%
CapEx$27.0K
Free cash flow$59.6M-0.8%

Valuation

See full
Market cap$3.84B+2.7%

Profitability

See full
Gross margin86%-0.2pp
Operating margin44.8%+1.6pp
Net margin37.1%+0.2pp
FCF margin34.9%-15.2pp

Returns & leverage

See full
Return on equity24.5%-4.6pp
Debt / equity0.0×
Current ratio7.1×+1.0×

Where this comes from

Calculated from Catalyst Pharmaceutical’s reported figures.

Based on the most recent quarter.

The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Catalyst Pharmaceutical's peg ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Catalyst Pharmaceutical's PEG ratio?
Catalyst Pharmaceutical (CPRX) reported PEG ratio of 1.1× in Q1 2026.
How has Catalyst Pharmaceutical's PEG ratio changed year-over-year?
Catalyst Pharmaceutical's PEG ratio increased by 1430.3% year-over-year, from 0.1× to 1.1×.
What is the long-term trend for Catalyst Pharmaceutical's PEG ratio?
Over 3 years (2020 to 2025), Catalyst Pharmaceutical's PEG ratio has grown at a 133.9% compound annual growth rate (CAGR), from 0× to 0.4×.
What does PEG ratio mean?
The P/E ratio divided by the trailing-twelve-month net-income growth rate (in percentage points). Adjusts the earnings multiple for the pace of earnings growth.